Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure

J. K. Teng, C. M. Kwan, L. J. Lin, L. M. Tsai, J. T. Cheng, W. C. Chang, J. H. Chen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

(±)-Dobutamine is a positive inotropic drug usually used to improve ventricular function in patients with congestive heart failure (CHF). However, it has been found that haemodynamic responses to dobutamine become blunted during continuous treatment. In this study we determined the time-dependent changes of β-adrenergic receptors in CHF patients treated with dobutamine. Seven CHF patients received a continuous intravenous infusion of dobutamine (5 μg . kg-1 . min-1) for 96 h. Blood samples were obtained before and every 24 h after starting the therapy. The density of β-adrenergic receptors on mononuclear leukocytes and the plasma concentrations of norepinephrine and epinephrine were determined. During dobutamine treatment the receptor density (fmol . mg-1, mean ± SEM) gradually decreased from 42.8 ± 4.4 (baseline) to 31.4 ± 3.3 (P

Original languageEnglish
Pages (from-to)1349-1353
Number of pages5
JournalEuropean Heart Journal
Volume14
Issue number10
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Dobutamine
Adrenergic Receptors
Congestive Heart Failure
Mononuclear Leukocytes
Leukocytes
Down-Regulation
Heart Failure
Norepinephrine
Hemodynamics
Ventricular Function
Blood
Therapeutics
Plasmas
Scanning electron microscopy
Intravenous Infusions
Receptor
Epinephrine
Therapy
Baseline
Drugs

Keywords

  • β-adrenergic receptor
  • Congestive heart failure
  • Dobutamine
  • Down-regulation
  • Drug tolerance

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology

Cite this

Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure. / Teng, J. K.; Kwan, C. M.; Lin, L. J.; Tsai, L. M.; Cheng, J. T.; Chang, W. C.; Chen, J. H.

In: European Heart Journal, Vol. 14, No. 10, 1993, p. 1349-1353.

Research output: Contribution to journalArticle

Teng, J. K. ; Kwan, C. M. ; Lin, L. J. ; Tsai, L. M. ; Cheng, J. T. ; Chang, W. C. ; Chen, J. H. / Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure. In: European Heart Journal. 1993 ; Vol. 14, No. 10. pp. 1349-1353.
@article{fc04be42e92d4ac991598abb5b6e1778,
title = "Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure",
abstract = "(±)-Dobutamine is a positive inotropic drug usually used to improve ventricular function in patients with congestive heart failure (CHF). However, it has been found that haemodynamic responses to dobutamine become blunted during continuous treatment. In this study we determined the time-dependent changes of β-adrenergic receptors in CHF patients treated with dobutamine. Seven CHF patients received a continuous intravenous infusion of dobutamine (5 μg . kg-1 . min-1) for 96 h. Blood samples were obtained before and every 24 h after starting the therapy. The density of β-adrenergic receptors on mononuclear leukocytes and the plasma concentrations of norepinephrine and epinephrine were determined. During dobutamine treatment the receptor density (fmol . mg-1, mean ± SEM) gradually decreased from 42.8 ± 4.4 (baseline) to 31.4 ± 3.3 (P",
keywords = "β-adrenergic receptor, Congestive heart failure, Dobutamine, Down-regulation, Drug tolerance",
author = "Teng, {J. K.} and Kwan, {C. M.} and Lin, {L. J.} and Tsai, {L. M.} and Cheng, {J. T.} and Chang, {W. C.} and Chen, {J. H.}",
year = "1993",
language = "English",
volume = "14",
pages = "1349--1353",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Down-regulation of β-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure

AU - Teng, J. K.

AU - Kwan, C. M.

AU - Lin, L. J.

AU - Tsai, L. M.

AU - Cheng, J. T.

AU - Chang, W. C.

AU - Chen, J. H.

PY - 1993

Y1 - 1993

N2 - (±)-Dobutamine is a positive inotropic drug usually used to improve ventricular function in patients with congestive heart failure (CHF). However, it has been found that haemodynamic responses to dobutamine become blunted during continuous treatment. In this study we determined the time-dependent changes of β-adrenergic receptors in CHF patients treated with dobutamine. Seven CHF patients received a continuous intravenous infusion of dobutamine (5 μg . kg-1 . min-1) for 96 h. Blood samples were obtained before and every 24 h after starting the therapy. The density of β-adrenergic receptors on mononuclear leukocytes and the plasma concentrations of norepinephrine and epinephrine were determined. During dobutamine treatment the receptor density (fmol . mg-1, mean ± SEM) gradually decreased from 42.8 ± 4.4 (baseline) to 31.4 ± 3.3 (P

AB - (±)-Dobutamine is a positive inotropic drug usually used to improve ventricular function in patients with congestive heart failure (CHF). However, it has been found that haemodynamic responses to dobutamine become blunted during continuous treatment. In this study we determined the time-dependent changes of β-adrenergic receptors in CHF patients treated with dobutamine. Seven CHF patients received a continuous intravenous infusion of dobutamine (5 μg . kg-1 . min-1) for 96 h. Blood samples were obtained before and every 24 h after starting the therapy. The density of β-adrenergic receptors on mononuclear leukocytes and the plasma concentrations of norepinephrine and epinephrine were determined. During dobutamine treatment the receptor density (fmol . mg-1, mean ± SEM) gradually decreased from 42.8 ± 4.4 (baseline) to 31.4 ± 3.3 (P

KW - β-adrenergic receptor

KW - Congestive heart failure

KW - Dobutamine

KW - Down-regulation

KW - Drug tolerance

UR - http://www.scopus.com/inward/record.url?scp=0027434162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027434162&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 1349

EP - 1353

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 10

ER -